Hostname: page-component-cd9895bd7-fscjk Total loading time: 0 Render date: 2024-12-28T19:59:57.819Z Has data issue: false hasContentIssue false

Omicron Variant in Mexico: the Fourth COVID-19 Wave

Published online by Cambridge University Press:  16 June 2022

Sergio Isaac De La Cruz-Hernández*
Affiliation:
Department of Virology, Institute of Epidemiological Diagnosis and Reference (InDRE), Ministry of Health of Mexico, CDMX, Mexico
Ana Karen Álvarez-Contreras
Affiliation:
Department of Microbiology, National School of Biological Science, National Polytechnic Institute, CDMX, México
*
Corresponding author: Sergio Isaac De La Cruz-Hernández, Emails: delacruz.hernandez.si@gmail.com, sergio.delacruz@salud.gob.mx
Rights & Permissions [Opens in a new window]

Abstract

Type
Letter to the Editor
Copyright
© The Author(s), 2022. Published by Cambridge University Press on behalf of Society for Disaster Medicine and Public Health, Inc.

Just when several countries around the world were leaving behind the wave caused by the Delta variant of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS CoV-2), the Omicron variant emerged causing millions of infections worldwide. Reference Singhal1,2 This new variant of SARS CoV-2 is characterized by having 32 mutations in the spike protein. It is noteworthy that the Delta variant has only 5 mutations in its protein, which is the main antigenic target of antibodies produced by both infections and vaccination. Reference Chen, Wang and Gilby3 Furthermore, the Omicron variant is up to 2.8 times more transmissible than the Delta variant, which was more transmissible than the Alpha variant. Reference Chen, Wang and Gilby3,Reference Earnest, Uddin and Matluk4

In early November 2021, Mexico had already left behind the third wave of coronavirus disease 2019 (COVID-19) triggered by the Delta variant. Reference De La-Cruz Hernández and Barrera-Badillo5 However, at the end of 2021, the Omicron variant was increasing its presence, which at the same time caused the fourth wave of COVID-19, characterized by the high number of COVID-19 cases in the country (r = 0.5299, P < 0.00001). 2,6 Thus, in less than 2 weeks, this fourth wave had already reached the maximum number of cases registered during the third wave caused by the Delta variant, and 2 weeks later the cases increased by more than 200%; with which, this fourth wave of COVID-19 reached its peak (Figure 1). On the other hand, although there was no correlation between the presence of the Omicron variant and daily new deaths, these also increased during this fourth wave of COVID-19 (r = 0.1154, P = 0.3638). 2,6 Nevertheless, the deaths observed through this fourth wave were lower in comparison with those reported during the third wave triggered by the Delta variant, which also had fewer deaths when compared to the second wave. Thus, although the number of daily new cases has increased with each new wave, the number of deaths has also decreased at the same time (Figure 1). It is worth noting that, during the second wave of COVID-19 in January 2021, the percentage of vaccinated people started to increase in Mexico, but only 0.5% of the population received the vaccine. During the third wave, people who had received at least one dose of the vaccine represented 45% of the population, while in the fourth COVID-19 wave, this percentage increased to 65% (Figure 1). 2,7

Figure 1. Daily new cases and deaths, and the percentage of vaccinated people during the last COVID-19 waves in Mexico.

Reports of daily new cases (a) and deaths (b) were obtained from Johns Hopkins University & Medicine Coronavirus Resource Center. 2 Proportions of vaccinated people (indicated by dashed lines) were obtained from Our World in Data. 7

Only in the text we show the Pearson´s correlation coefficient to test the association between the proportion of reported sequences of the Omicron variant with daily new cases and daily new deaths, from the beginning to the peak of the fourth COVID-19 wave. The proportions of sequences (not cases) of the Omicron variant (BA.1) from Mexico were obtained from CoVariants, Enabled by data from GISAID. 6

Although some studies have suggested that vaccines cannot prevent new infections, the risk of severe disease, hospitalization, and death decreases in vaccinated people. Reference Bian, Gao and Gao8,Reference Johnson, Amin and Ali9 Therefore, it is important to increase vaccination coverage and booster doses to strengthen the immune response against this virus.

However, we must consider that if the virus remains highly transmissible, the risk of contagion is present and increases when people are in close contact with others. This in turn increases the possibility that the virus could mutate again, and a new variant could emerge, thus provoking a new wave of infections, and repeating the vicious circle. Reference Otto, Day and Arino10,Reference Novelli, Colona and Pandolfi11 Unfortunately, we have seen this vicious circle repeating itself. Now the Omicron variant has new sub lineages, one of them is the variant BA.2, which emerged in China in early March, 2022. This new Omicron variant was responsible for thousands of infections which had not been seen in this country since the beginning of this pandemic. 2,Reference Lewis12 Therefore, we must maintain strict measures such as social distancing and the use of face masks until the end of this public health emergency of international concern.

We can apply all the knowledge acquired through this pandemic to take care of ourselves, prevent new waves of infections and be prepared for another pandemic in the future.

Acknowledgments

We would like to thank Francisco José Aréchiga-Ceballos for reviewing this manuscript, and Andrés Gerardo Tapia-Flores for supporting the statistical analysis.

Author contributions

Sergio Isaac De La Cruz-Hernández wrote the manuscript, analyzed the epidemiological data along with the proportion of vaccinated people, and the reported sequences of the Omicron variant of SARS-CoV-2 and finally, he assisted in designing the figures.

Ana Karen Álvarez-Contreras obtained and analyzed all the data from Johns Hopkins University & Medicine, Coronavirus Resource Center, along with other sources such as Our World in Data, and CoVariants, enabled by data from GISAID. She also assisted in designing the figures.

Conflict of interest

The authors declare that there are no conflicts of interest.

References

Singhal, T. The emergence of Omicron: challenging times are here again! Indian J Pediatr. 2022;89(5):490-496. doi: 10.1007/s12098-022-04077-4 CrossRefGoogle Scholar
Johns Hopkins University & Medicine. Coronavirus Resource Center. https://coronavirus.jhu.edu. Accessed May 30, 2022.Google Scholar
Chen, J, Wang, R, Gilby, NB, et al. Omicron variant (B.1.1.529): infectivity, vaccine breakthrough, and antibody resistance. J Chem Inf Model. 2022;62(2):412-422. https://doi.org/10.1021/acs.jcim.1c01451 CrossRefGoogle ScholarPubMed
Earnest, R, Uddin, R, Matluk, N, et al. Comparative transmissibility of SARS-CoV-2 variants Delta and Alpha in New England, USA. Cell Rep Med. 2022;3(4):100583. https://doi.org/10.1016/j.xcrm.2022.100583 Google ScholarPubMed
De La-Cruz Hernández, SI, Barrera-Badillo, G. The Delta variant triggers the third wave of COVID-19 in Mexico. Disaster Med Public Health Prep. 2022;21:1-5. https://doi.org/10.1017/dmp.2022.49 Google Scholar
CoVariants Enabled by data from GISAID. Overview of variants/mutations. https://covariants.org/per-variant. Accessed May 30, 2022.Google Scholar
Our World in Data. Coronavirus (COVID-19). https://ourworldindata.org/covid-vaccinations?country=MEX. Accessed May 30, 2022.Google Scholar
Bian, L, Gao, Q, Gao, F, et al. Impact of the Delta variant on vaccine efficacy and response strategies. Expert Rev Vaccines. 2021;20(10):1201-1209. https://doi.org/10.1080/14760584.2021.1976153 CrossRefGoogle ScholarPubMed
Johnson, AG, Amin, AB, Ali, AR, et al. COVID-19 incidence and death rates among unvaccinated and fully vaccinated adults with and without booster doses during periods of delta and omicron variant emergence - 25 U.S. Jurisdictions, April 4-December 25, 2021. MMWR. 2022;71(4):132-138. doi: 10.15585/mmwr.mm7104e2 Google Scholar
Otto, SP, Day, T, Arino, J, et al. The origins and potential future of SARS-CoV-2 variants of concern in the evolving COVID-19 pandemic. Curr Biol. 2021;31(14):R918-R929. https://doi.org/10.1016/j.cub.2021.06.049 CrossRefGoogle ScholarPubMed
Novelli, G, Colona, VL, Pandolfi, PP. A focus on the spread of the delta variant of SARS-CoV-2 in India. Indian J Med Res. 2021;153(5&6):537-541. doi: 10.4103/ijmr.ijmr_1353_21 CrossRefGoogle ScholarPubMed
Lewis, D. Will Omicron finally overpower China’s COVID defenses? Nature. 2022;604(7904):17-18. doi: 10.1038/d41586-022-00884-z CrossRefGoogle Scholar
Figure 0

Figure 1. Daily new cases and deaths, and the percentage of vaccinated people during the last COVID-19 waves in Mexico.Reports of daily new cases (a) and deaths (b) were obtained from Johns Hopkins University & Medicine Coronavirus Resource Center.2 Proportions of vaccinated people (indicated by dashed lines) were obtained from Our World in Data.7Only in the text we show the Pearson´s correlation coefficient to test the association between the proportion of reported sequences of the Omicron variant with daily new cases and daily new deaths, from the beginning to the peak of the fourth COVID-19 wave. The proportions of sequences (not cases) of the Omicron variant (BA.1) from Mexico were obtained from CoVariants, Enabled by data from GISAID.6